Drug intelligence / Profile preview

anti-Ly6C antibody

Development stage
Preclinical
Lead developer
BioLegend
Modality
Monoclonal Antibodies → Antibody-Based Therapeutics
Administration
Intraperitoneal, Intravenous
01

Overview

Anti-Ly6C antibody refers to a class of monoclonal antibodies used primarily in preclinical research to target the Lymphocyte antigen 6 complex locus C (Ly6C) protein. Ly6C is a glycosylphosphatidylinositol (GPI)-anchored cell surface protein expressed on various myeloid cells in mice, including inflammatory monocytes, neutrophils, and a subset of myeloid-derived suppressor cells (mMDSCs). In experimental models, these antibodies are utilized for the identification, characterization, and systemic depletion of Ly6C-positive cell populations to study their role in inflammation, infection, and tumor progression. In the context of glioblastoma research, anti-Ly6C antibodies have been investigated for their ability to deplete monocytic MDSCs, although their efficacy can be limited by the rapid systemic and local proliferation of these cells within the tumor microenvironment.

Other names
Ly6C antibodyLy-6C antibodyLy 6C antibodyanti-mouse Ly6CLy-6C monoclonal antibodyLy6C monoclonal antibodyLy 6C monoclonal antibody
02

Targets

Ly6G

Beyond the preview

Go deeper on anti-Ly6C antibody.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on anti-Ly6C antibody.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call